Business Wire

CA-SHIFTLEFT

Share
ShiftLeft to Present at No Hat Conference 2021

ShiftLeft, Inc ., an innovator in automated application security testing, today announced that its Chief Scientist, Fabian Yamaguchi, and Security Research Engineer, Claudiu-Vlad Ursache, will give a presentation focused on Ghidra2cpg at the No Hat Conference in Bergamo, Italy on November 20, 2021. The No Hat 2021 is a security conference organized to bring together specialists, professionals and hobbyists operating in the field of computer security and privacy.

Event Details:

Who: Fabian Yamaguchi, Chief Scientist and Claudiu-Vlad Ursache, Security Research Engineer, ShiftLeft
What: Virtual Session: Presentation on Ghidra2cpg: From graph queries to vulnerabilities in binary code
When: Saturday, November 20, 2021, 11:15am – 12:00pm CET
Where: Centro Congressi Giovanni XXIII - Bergamo, Italy

For more information, visit : https://www.nohat.it/program

Session Abstract - Ghidra2cpg: From graph queries to vulnerabilities in binary code

Uncovering bugs in source code is hard enough as it is, but when all you have is a binary, the importance of tooling becomes undeniable. Disassemblers such as IDA Pro, Ghidra, BinaryNinja or Radare2 provide a strong foundation for an investigation but are designed primarily to assist in what remains a manual investigation. This leaves room for partial automations that make the discovery process less painful.

Fabian and Claudiu were looking to design a search tool for binary code that allows them to uncover instances of programming patterns linked to vulnerabilities - at scale and for multiple major instruction sets. In this talk, they will present ghidra2cpg, an extension for the open-source code mining platform Joern that enables it to process binary code. Together, Joern and ghidra2cpg enable you to quickly uncover the attack surface, search for variants of known vulnerabilities, and gather information interactively using a query language.

In this session they will show how to write queries for the system that describe bugs in source code and introduce corresponding queries for binary code, highlighting what's harder and what is easier to describe when looking at the machine code directly. They will also be looking at modern consumer-grade router firmware and may drop a zero-day or two in the process.

About Fabian Yamaguchi

Fabian is Chief Scientist at ShiftLeft Inc and an Associate Professor Extraordinary at Stellenbosch University. He has over 15 years of experience in the security domain, where he has worked as a security consultant and researcher, focusing on manual and automated vulnerability discovery. Throughout his work, he has identified previously unknown vulnerabilities in popular system components and applications such as the Microsoft Windows kernel, the Linux kernel, the Squid proxy server, and the VLC media player. He has presented his findings and techniques at both major industry conferences such as BlackHat USA, DefCon, First, and CCC, and renowned academic security conferences such as ACSAC, Security and Privacy, and CCS. He holds a master’s degree in computer engineering from Technical University Berlin, as well as a PhD in computer science from the University of Goettingen.

About Claudiu-Vlad Ursache

Claudiu-Vlad Ursache is a Security Research Engineer at ShiftLeft, having recently entered cybersecurity after a decade of writing software. In his day-to-day job he builds static analysis tools and his current research focuses on IoT firmware.

About ShiftLeft

ShiftLeft enables software developers and application security teams to radically reduce the attackability of their applications by providing near-instantaneous security feedback on software code during every pull request. By analyzing application context and data flows in near real-time with industry leading accuracy, ShiftLeft empowers developers and appsec team to find and fix the most serious vulnerabilities faster. Using its patented graph analysis that combines code attributes and analyzes actual attack paths based on real application architecture, ShiftLeft’s platform scans for attack context and pathways typical of modern applications, across APIs, OSS, internal microservices and first-party business logic code, and then provides detailed guidance on risk remediation within existing development workflows and tooling. ShiftLeft CORE, a unified code security platform, combines the company’s flagship NextGen Static Analysis (NG SAST), Intelligent Software Composition Analysis (SCA), and contextual security training through ShiftLeft Educate to provide developers and application security teams the fastest, most accurate, most relevant, and easiest to use automated application security and code analysis platform.

Backed by Bain Capital Ventures, Mayfield, Thomvest Ventures, and SineWave Ventures, ShiftLeft is based in Santa Clara, CA. To learn how ShiftLeft keeps AppSec in sync with the rapid pace of DevOps, see https://www.shiftleft.io/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Europe's GetVocal raises $26m to scale trustworthy conversational agents for enterprises18.11.2025 10:00:00 CET | Press release

Series A led by Creandum, with Elaia and Speedinvest, will accelerate the product development of GetVocal’s AI customer experience platform GetVocal, Europe’s leading provider of conversational AI agents for enterprise customer support, today announced the closing of a $26 million Series A investment round led by Creandum with participation from Elaia and Speedinvest, bringing GetVocal’s total fundraising to $30 million. GetVocal will use the funding to fuel product innovation, market expansion, and hiring across Europe as the company accelerates its mission to help enterprises build hybrid human-AI workforces. Founded in 2023 by AI entrepreneurs Roy Moussa and Antonin Bertin, GetVocal is headquartered in Paris, with a 60-strong team spread across Europe. It serves 23 markets, with a stronghold in France and Portugal, and a rapidly growing presence in the UK and DACH. The company tackles one of the biggest barriers to conversational AI adoption – the lack of trust and confidence in bla

Ant Group Unveils China’s First Multimodal AI Assistant with Code-Driven Outputs18.11.2025 09:05:00 CET | Press release

Ant Group today launched LingGuang, a next-generation multimodal AI assistant and the first of its kind in China that interacts with users through code-driven outputs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117438567/en/ Equipped with the capability to understand and produce language, image, voice and data, LingGuang delivers precise, structured responses to complex queries through 3D models, audio clips, charts, animations, interactive maps, and even immediately generated applications, in addition to traditional text-based conversation. Designed around three key features, LingGuang aims to make complex knowledge simpler and more intuitive, transforming how users access information and interact with AI tools. Fast Research: LingGuang responds to user questions or keywords with dynamic, multimodal content, making research on any topic clearer and more engaging. Its 3D digital modeling capability transcends traditio

SkySparc Appoints Oliver Bussmann as Chairman of the Board18.11.2025 09:00:00 CET | Press release

Appointment of industry veteran follows majority growth investment from Bregal Milestone SkySparc, a trusted global provider of digital transformation solutions for treasury and finance organizations, today announced the appointment of Oliver Bussmann as Chairman of the Board, following the closing of a majority growth investment from Bregal Milestone, a leading European software private equity firm. As former Global CIO at UBS and SAP, Bussmann has a proven track record of scaling B2B software and services across the Office of the CFO, Financial Services, RegTech, and WealthTech. Throughout his career, he has guided organizations through complex SaaS transitions, strategic M&A, and go-to-market acceleration – delivering multiple successful exits and sustained enterprise growth. Bussmann will help steer SkySparc’s technology and value-creation agenda, as Chairman, leveraging his network across financial services and technology to accelerate innovation, expand AI adoption, and drive lon

European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 08:23:00 CET | Press release

Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20%1,3Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency3 Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline inf

Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 08:00:00 CET | Press release

After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research to the new IDEAL Japan initiativeThe “Innovation Debiopharm Academia Life Science” (IDEAL) program is designed to financially and scientifically support academic research with the goal of accelerating the translation of innovation into novel therapies for patientsThe first IDEAL Japan agreement was signed with the National Cancer Center Japan Research Institute Laboratory of Genome Stability Maintenance to advance research in early-stage colon cancer Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye